Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

10.22
-0.2000-1.92%
Post-market: 10.15-0.0700-0.68%19:30 EDT
Volume:228.44K
Turnover:2.34M
Market Cap:499.61M
PE:-3.19
High:10.61
Open:10.49
Low:10.10
Close:10.42
52wk High:14.53
52wk Low:2.22
Shares:48.89M
Float Shares:19.28M
Volume Ratio:0.75
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2084
EPS(LYR):-3.4309
ROE:-36.58%
ROA:-22.34%
PB:1.44
PE(LYR):-2.98

Loading ...

May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Mar 24, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Jan 29, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 22, 2024

Major Issues Report

Form 8-K - Current report
Sep 03, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 29, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 01, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 01, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jul 29, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Jul 29, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Jul 22, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Correspondence

Form CORRESP - Correspondence